We are organising a symposium, n° 44 Tissue engineering for osteoradionecrosis at the 9th World Biomaterials Congress/meeting, which is taking place in Chengdu, China from June 1 – 5, 2012. We are delighted that two of the world leaders in the field, Daniel Alam from the Cleveland Clinic Foundation, USA and Prof. Olivier Malard, ENT department, Nantes Hospital France, have agreed to give a keynote presentation and a lecture at this symposium.
Treatment of squamous cell carcinomas requires large therapeutic surgical bone removal in association with external radiation therapy. The surgery can be performed either before a complementary radiation therapy, or after radiation therapy, as in the case of tumor recurrence. The side-effects of surgical treatments are major aesthetic and functional disorders know as Radionecrosis.The standard surgical technique of reconstruction is the use of micro-anastomosed free-flaps. Given these risks of failure and complications, the purpose of this symposia was to propose and discuss new surgical technologies alternatives. Smart biomaterials has been considered as an alternative to autogenous bone grafts, in association with tissue engineering technolgy. Selected speakers will cover all the solutions in development.
This symposium is aimed Given your expertise in this area, you are cordially invited to submit an abstract for this symposium. The Abstract Submission is currently open and will close on September, 30Th, 2011. To be considered, please ensure to select our symposium from the list provided during the abstract submission process.
Symposium n° 44 Tissue engineering for osteoradionecrosis
9th WBC Chengdu,China
New Century International
1 - 5 June 2012
CALL FOR ABSTRACTS - Deadline to submit September 30, 2011